Raze Therapeutics, a leading next generation cancer metabolism company, announced today the expansion of its Scientific Advisory Board (SAB) with the addition of three leaders in oncology drug discovery and development.
Raze Therapeutics, a leading next generation cancer metabolism company, announced today the expansion of its Scientific Advisory Board (SAB) with the addition of three leaders in oncology drug discovery and development.